Archive for August 2023
Wu names two new BPDA board members, as agency awaits other changes
The mayor once campaigned to abolish the agency, but she is now working to create a new version of the BPDA aligned with her vision for planning and development. Much of that vision remains a work in progress. Read More
Read MoreSage shares cut in half after postpartum drug approval. Here’s what happened.
The Cambridge drugmaker saw its market value drop by about $1 billion in the first minutes of trading Monday, following a partial approval of a new depression drug late Friday. Cambridge-based Sage had applied to market the depression drug, zuranolone, as a treatment for both major depressive disorder (MDD) and postpartum depression (PPD). The U.S.…
Read MoreCIC in line for federal grant to support underserved entrepreneurs
CIC is the only organization serving Massachusetts entrepreneurs to be selected by the U.S. Department of Commerce for funding to help underserved entrepreneurs. Read More
Read MoreMIT raised millions for startup it shut down after accusations of research misconduct
Documents obtained by the Boston Business Journal suggest the university raised millions of dollars, and even appears to have nabbed a federal grant, for what it touted as a cutting-edge agricultural startup before that program was shut down in 2020 following allegations of research misconduct. Read More
Read MoreMass. business confidence pushes back into optimistic territory in July
Massachusetts employer confidence pushed back into optimistic territory in July, after falling into pessimistic territory in May for the first time since 2020. Read More
Read MorePostpartum depression drug developed by Sage, Biogen approved by FDA
A new depression drug has received the green light from the U.S. Food and Drug Administration after years of development by two Cambridge drugmakers. Zuranolone, a new drug co-developed by Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics Inc. (Nasdaq: SAGE), scored an FDA approval late Friday — but the approval was only for postpartum depression,…
Read MoreGolf keeps growing in popularity in wake of Covid, says Acushnet CEO
The CEO of the Fairhaven-based company behind the golf brand Titleist says that the sport is still growing in popularity, showing its Covid-fueled surge is lasting longer than many had predicted. Read More
Read MoreBoston-based Scripta teams up with Mark Cuban’s low-cost drug company
Scripta Insight’s customers — who are self-insured employers, health plans and their members — will soon have access to drugs through Cost Plus Drugs. Read More
Read MoreFed small-business loan rule on data collection hits big roadblock
The rule would require banks to gather demographic data on all small-business loans. Read More
Read MoreAnna Jaques Hospital promotes chief medical officer to president
The community hospital based in Newburyport has appointed Glenn Focht as its next president. Read More
Read More